Investment
Features
FeesSafety
Academy
More
Pluang+

XRP treasury firm Evernorth raises $30M to buy more XRP and pursue Nasdaq listing

Market News
18 Sep 2026
UToday
View Source
Bullish
XRP treasury firm Evernorth raises $30M to buy more XRP and pursue Nasdaq listing

Evernorth, the world's largest XRP treasury firm, secured $30 million in funding from South Korean firm NH Investment & Securities through convertible notes. The funds will be used to purchase more XRP tokens and support Evernorth's merger with a SPAC, aiming for a Nasdaq listing under the ticker XRPN. This move will allow traditional investors to gain exposure to XRP via the stock market, marking a significant step in institutional adoption of the Ripple-associated token.

The XRP treasury firm Evernorth's $30 million raise is notable context for readers. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Sep 18, 2026 22:51 WIB: out of 50 major cryptocurrencies priced on Pluang, 45 rose and 4 fell today. Among notable movers, NEO rose 8.59% to Rp40.799 with a typical hold time of 95 days, ATOM increased 8.54% to Rp29.730 with 72% buy order activity, and VET gained 8.36% to Rp138 despite 94% sell order activity.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
4 hours ago
Semiconductor ETFs remain strong buys amid AI-driven demand and investment growth.

Semiconductor ETFs remain strong buys amid AI-driven demand and investment growth.

iShares Semiconductor ETF and VanEck Semiconductor ETF are recommended as strong buys due to robust capital investment driven by AI infrastructure and sector demand outpacing the broader market. The AI buildout is attracting unprecedented capital int...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App